Invasive cleavage of nucleic acids

• US 5,985,557 A
• Filed: 11/26/1996
• Issued: 11/16/1999
• Est. Priority Date: 01/24/1996
• Status: Expired due to Term

• Current Assignee: Gen-Probe Incorporated (Hologic Incorporated)
• Original Assignee: Third Wave Technologies Incorporated (Hologic Incorporated)
• Inventors: Prudent, James R., Hall, Jeff G., Dahlberg, James E., Lyamichev, Victor I., Brow, Mary Ann D.
• Primary Examiner(s): Campbell, Eggerton A.
• Application Number:
  US08/756,386
• Time in Patent Office: 1,085 Days
• Field of Search: 435/6, 435/91.1, 435/183, 436/94, 536/23.1, 536/24.3, 536/24.33
• US Class Current: 435/6.1
• CPC Class Codes: C12N 9/22 Ribonucleases RNAses, DNAses catalytic nucleic acids C12N15/113
• CPC Class Codes: C12Q 1/6823 Release of bound markers
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 1/683 involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
• CPC Class Codes: C12Q 2525/301 Hairpin oligonucleotides
• CPC Class Codes: C12Q 2561/109 Invader technology
• CPC Class Codes: C12Q 2563/149 Particles, e.g. beads
• CPC Class Codes: C12Q 2565/525 characterised by the capture oligonucleotide being double stranded
• CPC Class Codes: Y10S 435/81 Packaged device or kit
• CPC Class Codes: Y10S 435/822 using bacteria or actinomycetales

Abstract

The present invention relates to means for the detection and characterization of nucleic acid sequences, as well as variations in nucleic acid sequences. The present invention also relates to methods for forming a nucleic acid cleavage structure on a target sequence and cleaving the nucleic acid cleavage structure in a site-specific manner. The structure-specific nuclease activity of a variety of enzymes is used to cleave the target-dependent cleavage structure, thereby indicating the presence of specific nucleic acid sequences or specific variations thereof.

Claims

1. A composition comprising a cleavage structure, said cleavage structure comprising:

a) a target nucleic acid, said target nucleic acid comprising a first region, a second region, a third region and a fourth region, wherein said first region is located adjacent to and downstream from said second region, said second region is located adjacent to and downstream from said third region and said third region is located adjacent to and downstream from said fourth region;

b) a first oligonucleotide having a 5'"'"' portion and a 3'"'"' portion, wherein said 5'"'"' portion of said first oligonucleotide comprises a sequence complementary to said second region of said target nucleic acid and wherein said 3'"'"' portion of said first oligonucleotide comprises nucleotides that are base-paired to said third region of said target nucleic acid; and

c) a second oligonucleotide having a 5'"'"' portion, a central portion, and a 3'"'"' portion, wherein said 5'"'"' portion of said second oligonucleotide comprises nucleotides that are base-paired to said first region of said target nucleic acid, wherein said central portion of said second oligonucleotide comprises a sequence complementary to said second region of said target nucleic acid, and wherein said 3'"'"' portion of said second oligonucleotide consists of a single nucleotide that is not base-paired to said target nucleic acid.

2. The cleavage structure of claim 1, wherein said first region of said target nucleic acid has a length of eleven to fifty nucleotides.

3. The cleavage structure of claim 1, wherein said second region of said target nucleic acid has a length of one to three nucleotides.

4. The cleavage structure of claim 1, wherein said third region of said target nucleic acid has a length of six to nine nucleotides.

5. The cleavage structure of claim 1, wherein said forth region of said target nucleic acid has a length of six to fifty nucleotides.

6. The cleavage structure of claim 1, wherein one or more of said first, and said second oligonucleotides contain a 3'"'"'-terminal dideoxynucleotide.

7. The cleavage structure of claim 1, further comprising a third oligonucleotide, wherein said third oligonucleotide comprises nuclcotides that are base-paired to said fourth region of said target nucleic acid.

8. The cleavage structure of claim 7, wherein said third oligonucleotide comprises a 3'"'"' terminal dideoxynucleotide.

9. A composition comprising a cleavage structure, said cleavage structure comprising:

a) a target nucleic acid, said target nucleic acid comprising a first region, a second region, and a third region, wherein said first region is located adjacent to and downstream from said second region, and said second region is located adjacent to and downstream of said third region;

b) a first oligonucleotide, wherein said first oligonucleotide comprises nucleotides that are base-paired to said second portion of said target nucleic acid; and

c) a second oligonucleotide having a 5'"'"' portion and a 3'"'"' portion, wherein said 5'"'"' portion of said second oligonucleotide comprises nucleotidcs that are base-paired to said first region of said target nucleic acid, wherein said 3'"'"' portion of said second oligonucleotide is located adjacent to and downstream of said base-paired nucleotides of said 5'"'"' portion of said second oligonucleotide, and said 3'"'"' portion of said second oligonucleotide consists of a single nucleotide that is not base-paired to said target nucleic acid.

10. The cleavage structure of claim 9, wherein said target nucleic acid comprises RNA.

11. The cleavage structure of claim 9, wherein said target nucleic acid comprises DNA.

12. The cleavage structure of claim 9, further comprising a third oligonucleotide, wherein said third oligonucleotide comprises nucleotides that are base-paired to said third region of said target nucleic acid, wherein said base-paired nucleotides of said third oligonucleotide are contiguous with said base-paired nucleotides of said first oligonucleotide.

13. The cleavage structure of claim 9, wherein one or more of said first and said second oligonucleotides contain a 3'"'"' terminal dideoxynucleotide.

14. The cleavage structure of claim 12, wherein said third oligonucleotide contains a 3'"'"' terminal dideoxynucleotide.

15. A composition comprising a cleavage structure, said cleavage structure comprising:

a) a first oligonucleotide;

b) a second oligonucleotide having a 5'"'"' portion and a 3'"'"' portion, wherein said 5'"'"' portion is contiguous with said 3'"'"' portion; and

c) a target nucleic acid, said target nucleic acid comprising a first region, a second region, and a third region, wherein said first region is contiguous with and downstream from said second region, and wherein said second region is contiguous with and downstream from said third region, wherein said second region consists of a portion of said target nucleic acid that is base paired to at least a portion of said first oligonucleotide, wherein said first region consists of a portion of said target nucleic acid that is base paired to at least a portion of said 5'"'"' portion of said second oligonucleotide, wherein said 3'"'"' portion of said second oligonucleotide consists of a single nucleotide that is not base-paired to said target nucleic acid.

16. The cleavage structure of claim 15, wherein said target nucleic acid comprises RNA.

17. The cleavage structure of claim 15, wherein said target nucleic acid comprises DNA.

18. The cleavage structure of claim 15, further comprising a third oligonucleotide, wherein said third region of said target nucleic acid consists of a portion of said target nucleic acid that is base paired to at least a portion of said third oligonucleotide.

19. The cleavage structure of claim 15, wherein one or more of said first and said second oligonucleotides contain a 3'"'"' terminal dideoxynucleotide.

20. The cleavage structure of claim 18, wherein said third oligonucleotide contains a 3'"'"' terminal dideoxynucleotide.